Research interests include:
Basic Science Research: Control of Phagocyte Function and novel applications of Flow Cytometry/kinetic flow imaging.
Translational-Clinical Research: Tuberculosis: diagnostics; treatment; community-based prevention; education; policy
Clinical interests include:
Dr. Bernardo is Professor of Medicine at Boston University School of Medicine. He attends on the pulmonary consult service and critical care unit at Boston Medical Center. He is active in local and national TB programmatic activities, including: National Tuberculosis Controllers’ Association where he has served as Executive Committee President from 2002 to the present. Dr. Bernardo is also an active member of the Advisory Committee on the Elimination of Tuberculosis (ACET; NTCA) and the Association of Public Health Laboratories Task Force on the Future of TB Laboratory Services. Dr. Bernardo is a co-investigator at the Northeast Tuberculosis Regional Training and Medical Consultation Center (CDC), and a TB Control Officer, Massachusetts Department of Public Health, Div of TB Prevention and Control. He is a Principal Investigator at the Boston University site, TB Trials Consortium and co-Principal Investigator, Massachusetts DPH site, TB Epidemiologic Studies Consortium;.
Outside of Boston Medical Center, Dr. Bernardo is a Pulmonary/TB Physician for Boston’s Health Care for the Homeless, Inc., with a weekly, full-service, evening TB Clinic at Pine Street Inn shelter, where Claire Murphy, RN, NP, and Dr Bernardo provide specialty care to persons with TB infection and disease.
Dr. Bernardo’s basic research interests include basic studies of the control of the phagovacuolar environment (human neutrophils and monomuclear phagocytes) using kinetic flow cytometry and novel flow cytometric techniques (NHLBI support), in collaboration with Elizabeth Simons, Ph.D., Professor of Biochemistry. For more details, please see our webpage of TB/HIV Basic Science Research.
- Research Professor, Biochemistry, Boston University School of Medicine
- Member, Pulmonary Center, Boston University
- University of Illinois, MD
- University of Illinois, BS
- Published on 8/1/2021
Eddy JJ, Seth B, White LF, Sulis CA, Fagan MA, Bernardo J. Decreasing time spent in airborne infection isolation during TB testing. Int J Tuberc Lung Dis. 2021 08 01; 25(8):665-667. PMID: 34330353.
- Published on 10/25/2020
Belok SH, Parikh R, Bernardo J, Kathuria H. E-cigarette, or vaping, product use-associated lung injury: a review. Pneumonia (Nathan). 2020; 12:12. PMID: 33110741.
- Published on 7/18/2020
Eddy JJ, Gadani KM, Tibbs A, Bernardo J, Cochran J, White LF, Horsburgh CR, Jacobson KR. Increasing Drug Resistance Among Persons With Tuberculosis in Massachusetts, 2009-2018. Open Forum Infect Dis. 2020 Aug; 7(8):ofaa300. PMID: 32855987.
- Published on 9/1/2017
Schoenberg NC, Barker AF, Bernardo J, Deterding RR, Ellner JJ, Hess DR, MacIntyre NR, Martinez FJ, Wilson KC. A Comparative Analysis of Pulmonary and Critical Care Medicine Guideline Development Methodologies. Am J Respir Crit Care Med. 2017 Sep 01; 196(5):621-627. PMID: 28731387.
- Published on 9/14/2015
Chiswick EL, Mella JR, Bernardo J, Remick DG. Acute-Phase Deaths from Murine Polymicrobial Sepsis Are Characterized by Innate Immune Suppression Rather Than Exhaustion. J Immunol. 2015 Oct 15; 195(8):3793-802. PMID: 26371253.
- Published on 5/2/2015
Lessem EM, Bernardo J, Reed C, Wegener DH. Informed use of bedaquiline for tuberculosis. Lancet. 2015 May 02; 385(9979):1724. PMID: 25943933.
- Published on 10/7/2013
Pollock NR, McAdam AJ, Pai M, Nardell EA, Bernardo J, Banaei N, Mobo J. Interferon ?-release assays for diagnosis of latent tuberculosis in healthcare workers in low-incidence settings: pros and cons. Clin Chem. 2014 May; 60(5):714-8. PMID: 24100806.
- Published on 5/22/2013
Marks SM, Cronin W, Venkatappa T, Maltas G, Chon S, Sharnprapai S, Gaeddert M, Tapia J, Dorman SE, Etkind S, Crosby C, Blumberg HM, Bernardo J. The health-system benefits and cost-effectiveness of using Mycobacterium tuberculosis direct nucleic acid amplification testing to diagnose tuberculosis disease in the United States. Clin Infect Dis. 2013 Aug; 57(4):532-42. PMID: 23697743.
- Published on 1/15/2013
Mancuso JD, Bernardo J, Mazurek GH. The elusive "gold" standard for detecting Mycobacterium tuberculosis infection. Am J Respir Crit Care Med. 2013 Jan 15; 187(2):122-4. PMID: 23322793.
- Published on 5/23/2012
Han LL, Elvin P, Bernardo J. Nonclinical selection criteria for maximizing yield of nucleic acid amplification tests in tuberculosis diagnosis. J Clin Microbiol. 2012 Aug; 50(8):2592-5. PMID: 22622440.
View 47 more publications: View full profile at BUMC